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INTRODUCTION
Preterm delivery is a problem in the field of ob-
stetry and perinatology due to the high incidence
of infant morbidity and mortality. Seventy percents
of neonatal mortality and morbidity were caused
by prematurity, with the mortality rate of 19,000.
Prematurity is also as the most important risk fac-
tor for neurologic disorder and infant develop-
mental disorder.1-5
The incidence rate of preterm delivery is 7-10%
(mean, 11%) of overall pregnancy.3 In the United
States, the incidence rate of preterm delivery is
12% and it causes 75% of neonatal death, whereas
in the developing countries, the incidence ranges
from 5% to 10%.3,6 In Indonesia, the prematurity
incidence ranges from 10 to 20%; while from Janu-
ary 1998 to December 2000, at Dr. Hasan Sadikin
Hospital Bandung, it was 8.2% of overall delivery
with perinatal death rate by 53.6%.5-7
Abstract
Objective: To know the difference of salivary estriol level between
patients with preterm birth and preterm pregnancy of 32-36 weeks
and to determine the correlation between the level of estriol in saliva
and the incidence of preterm delivery.
Methods: This research was a cross-sectional studies of 80 patients
in Dr. Hasan Sadikin Hospital and its networks. The subjects are 40
patients in labor and 40 patients in preterm pregnancy, that met the
inclusion criterias during the period September 2011 to November
2011. We took the salivary sample and examine the level of estriol.
The data were analyzed by Shapiro-Wilk and Mann Whitney test.
Result: The study found that the difference of salivary estriol levels
in preterm labor and preterm pregnancy groups was statistically sig-
nificant (p<0.05). The mean salivary estriol levels in preterm labor
group was 3438.75 while the mean value of estriol levels in preterm
pregnancy group was 686.10 and ranges of each group is 1188-
16338 and 88-1180.
Conclusion: The value of salivary estriol levels were higher in pre-
term labor compared to the level in preterm pregnancy.
[Indones J Obstet Gynecol 2012; 36-2: 66-70]
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Abstrak
Tujuan: Untuk mengetahui perbedaan kadar estriol saliva pada per-
salinan kurang bulan dan kehamilan kurang bulan pada usia 32-36
minggu dan menentukan hubungan kadar antara estriol saliva ter-
hadap kejadian persalinan kurang bulan.
Metode: Penelitian ini merupakan penelitian potong lintang terhadap
80 orang pasien di RS Dr. Hasan Sadikin dan beberapa rumah sakit
jejaring, 40 orang pasien dalam masa persalinan dan 40 orang pasien
dalam masa kehamilan yang memenuhi kriteria inklusi selama peri-
ode September 2011 sampai November 2011. Dilakukan pemeriksaan
kadar estriol saliva pada subjek penelitian. Data yang diperoleh di-
analisis dengan uji Shapiro-Wilk dan Mann Whitney.
Hasil: Didapatkan perbedaan kadar estriol saliva yang bermakna se-
cara statistik (p<0,05) antara kelompok persalinan kurang bulan dan
kelompok kehamilan kurang bulan. Rerata kadar estriol saliva pada
kelompok persalinan kurang bulan adalah 3438,75 dengan simpang
baku 3283,03 sedangkan nilai rerata kadar estriol pada kelompok ke-
hamilan kurang bulan adalah 686,10 dengan simpang baku 279,22
serta rentang masing-masing kelompok adalah 1188-16338 dan 88-
1180.
Kesimpulan: Dari hasil penelitian dapat ditarik kesimpulan bahwa
kadar estriol saliva pada persalinan kurang bulan lebih tinggi diban-
dingkan dengan kehamilan kurang bulan.
[Maj Obstet Ginekol Indones 2012; 36-2: 66-70]
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A healthy pregnancy, when reached full term, is
a large scale of hyperestrogenic state. The amount
of estrogen produced daily by syncythiotro-
phoblast for the last gestational weeks is equal to
that produced by ovaries of at least 1000 ovulatory
women in a day. In similar analogic manner, the
amount of estrogen produced by placenta within
one normal pregnancy is greater than the amount
that secreted by ovaries of 200 ovulatory women
within the same 40-week period. Such hyperestro-
genic state in pregnancy is an increasing condition
that is in line with the continuing pregnancy and
then halts promptly after labour.8-10
The estrogenic pathway in the human placenta
is different from that in ovary follicles (granulosa
cells) of non-pregnant women. Estrogen is pro-
duced in ovary de novo, from acetate or choles-
terol. In the human placenta, acetate or cholesterol,
even progresteron cannot function as precursor for
estrogen biosynthesis. C19-steroid consists of de-
hydroepiandrosteron, androstenedion, and testos-
teron are the precursors for estrogen biosynthesis.
In the human placenta, estradiol-17 is a product of
secretory estrogen. Besides, 16-hydroxyandros-
tenedion is altered into 16-hydroxyestron, which
will be turn into estriol before secreted by tro-
phoblast. Thus, syncitiotrophoblast secretes two
type of estrogen, i.e., estradiol-17 and estriol. In
non-pregnant women, urine estriol to estron plus
estradiol-17 concentration ratio is less than one.
This ratio increases up to 10 folds or more by
aterm, consequently occurring profound increased
and imbalanced in estriol formation during preg-
nancy. This can be accounted for the metabolic
change of estron or estradiol-17 leading to estriol
due to pregnancy. Moreover, neither estron nor es-
tradiol-17 are changed into estriol in the pla-
centa.8,11-12
Estriol for the first time was detected in the ma-
ternal blood at 9th weeks pregnancy and the level
continues increasing in plasma during pregnancy.
Three to five weeks before delivery, there is a surge
of blood estriol level.4 Subsequently, miometrial es-
trogen-receptor binding estriol gives rise uterotro-
phic response that when it continues it will pro-
mote the production of prostaglandin from endo-
metrial cells. The salivary estriol level indicates free
plasma estriol level. The examination of salivary
estriol is easier than that plasma estriol, non-inva-
sive, and more stable during transportation.13-15
The early study by Dame et al. indicated that
the salivary estriol/progesteron ratio was greater
than normal in the pregnant women who suffered
preterm spontaneous delivery. It was concluded
that idiopathic preterm delivery of the women with
intact membrane were preceded by the increased
salivary estriol level since 5 weeks before delivery,
leading to increased salivary estriol/progesterone
ratio.16-17
The latter study by an author’s team based on
Lanchelin’s study, suggested for the first time that
the salivary estriol level = 2.1 ng/ml after 22-weeks
pregnancy was the risk factor for preterm deliv-
ery.18-19 In the study by McGregor et al, involving
956 singleton-gravid mother, the salivary estriol
levels were examined weekly. They found that the
increased salivary levels were associated with the
increased risk for premature delivery. The study
concluded that the salivary estriol level that was
more than 2.3 ng/ml were a risk factor for prema-
ture delivery.5,19-20
METHOD
This research was a cross-sectional studies con-
ducted in Dr. Hasan Sadikin Hospital and its net-
works, including RSKIA (Mother and Child Hospi-
tal) Astana Anyar, RSU (General Hospital) Ujung-
berung, RSUD (Regional Hospital) Garut, RSUD
Sumedang and RSU Cibabat, from September to
November 2011. During this period, 80 study sub-
jects were recruited, consisting of 40 subjects in
the preterm gestation group and 40 subjects in the
preterm delivery group that met the inclusion cri-
teria.
The data collected includes maternal age, gesta-
tional age, parity, body mass index, and laboratory
tests (hemoglobin, hematocrit, leukocyte, and
thrombocyte) to exclude the occurence of infec-
tion; subsequently, followed with salivary sampling
to measure the salivary estriol level at Laboratory
Prodia Jakarta. All treatments were applied to all
subjects. The data were then analyzed by Shapiro-
Wilk and Mann Whitney test.
RESULTS
The characteristics of the subjects which was re-
corded included maternal age, parity, and body
mass index. Table 1 indicates that the mean mater-
nal age in the preterm delivery group was 28.35
(SD:5.84) and the range was between 17-38 years.
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As many as 55% of the subjects in this group were
in the age group of <24 years. In the preterm ges-
tation group, the mean age was 27.3 (SD:5.29) and
the range was between 16-37 years. As many as
67.5% of this population was in the age group of
24-34. Statistically, this differences were insignifi-
cant (p=0.402) . The characteristics of the subjects
were shown at the following table.
Table 1. The Characteristics of the Subjects by Age, Parity,
and Body Mass Index in the Mothers with Preterm Delivery
and with Preterm Pregnancy
Characteristics
Group
Significance
Preterm
Delivery
Preterm
Pregnancy
Maternal Age(year)
< 24
25-34
≥ 35
22
12
 6
11
27
 2
t=0.842
p=0.402
X(±SD)
Median
Range
28.35(5.84)
29.00
17-38
27.30(5.29)
28.50
16.37
Parity
0
1
2
3
4
18
 8
 7
 3
 4
 8
12
14
 4
 2
p=0.365
Body Mass Index
< 19.8
19-26
26.01-29.99
>30
 2
10
 3
 1
 0
 9
 4
 3
t=2.69
p=0.006
X(±SD)
Range
22.7(2.6)
19.6-28.1
26.4(4.2)
21.8-37.0
Note: t=t test, p=p-value
The most common parity history in the preterm
delivery group was nulliparity (45%) and that in
the preterm pregnancy group was 2 parity (35%).
This difference was not statistically significant
(p=0.365).
The mean body mass index (BMI) in the preterm
delivery group was 22.7 (SD:2.6) and the range
was 19.6-28.1. About 62,5% of this population was
in the BMI group of 19.9. The mean body mass in-
dex in the preterm delivery group was 26.4
(SD:4.2) and the range was 21.8-37.0. About
56.25% of this population was in the BMI group of
19.9-26. Statistically, the difference was siginificant
(p=0.006).
Table 2. Comparison of Salivary Estriol Levels between
Preterm Delivery and Preterm Pregnancy
Level
Group
Signi-
ficancePreterm
Delivery
Preterm
Pregnancy
Estriol (pg/ml)
X(±SD)
Range
3438.75(3283.03)
1188-16338
686.10(279.22)
88-1180
t=0.000
p=0.000
Notes: t=Mann-Whitney test, p=p-value
Table 2 shows the comparison of salivary estriol
level in preterm delivery and preterm pregnancy.
In the preterm delivery group, the mean level was
3438.75 (SD:3283.03) and the range was 1188-
16338. In the preterm pregnancy group, the mean
level was 686.10 (SD:279.22) and the range was
88-1180. The table indicates that the mean salivary
estriol level in the preterm delivery group was
higher compared to that in the preterm pregnancy
group. Based on the data, statistical tes indicated
that t-value was 0.000 with the p-value was signifi-
cant (p=0.000), showing that there was a differ-
ence of estriol levels between both groups.
Table 3. The Correlation of Age and Parity to Estriol Level
in Preterm Delivery
Correlation of Age and Parity
to Estriol Level rs p
Between Age and Estriol Level 0.187 0.249
Between Parity and Estriol Level 0.294s 0.115
Notes: rs=Pearson’s correlation coefficient
Table 3 indicates that the comparison between
age and estriol level showed a p-value of 0.249
(p>0.05), implying that it was not significant. This
means that there was no correlation between age
and estriol level in preterm delivery. Meanwhile,
the relationship between parity and estriol level
showed a p-value of 0.115 (p>0.05), meaning that
there was also no significant correlation between
parity and estriol level in preterm delivery.
DISCUSSION
In this study, Table 1 indicates that in preterm de-
livery, the majority of subject was in the age group
of less than 24 years; meanwhile, the mean mater-
nal age was 29 years. The too young or too old
maternal age was also became a risk factor for pre-
term delivery.  A Sweden study suggested that the
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mother’s age between 13-17 years during preg-
nancy increased the risk for preterm delivery for
two-fold than that at 20-24 years. Whilst, at 35
years old, the risk for preterm delivery increased
two-fold than that in 20-30 years as control age.21
According to Creasy, the association between
maternal age and preterm delivery was that the
younger the preterm delivery was, the greater the
possibility for preterm delivery. The mother’s age
less than 20 years and more than 40 years had a
risk for preterm delivery. The age of the mother
less than 18 years had a greater risk than that of
20 years old. The incidence of preterm delivery
was found considerable in young-age group due to
socioeconomic, education, and life-style factors.4
From this study results, the majority of parity
history in preterm delivery was nulliparity (45%).
According to several studies, preterm delivery was
more frequent in primipara, and other several
studies also suggested that the risk in preterm de-
livery increased after the  fourth pregnancies.
The characteristics of the study subjects by body
mass index showed that the mean of body mass
index in the preterm delivery group was 22.7 with
the range of 19.6-28.1. The majority of subject in
preterm delivery had a body mass index between
19.96-26.
Table 1 indicates that the characteristics of sub-
ject, i.e., maternal age and parity, statistically
showed no significant difference (p>0.005). it is
concluded that both group were feasible to com-
pare. Meanwhile, in the body mass index, statistical
analysis showed a significant difference (p<0.05).
This can be explained by Cohen et al that there was
a significant association between mother’s low
body weight or body mass index during pregnancy
with preterm delivery. Low body weight or BMI
and poor nutrition in pregnancy are risk factors for
preterm birth.21-22
The subjects in this study that met the inclusion
criteria had received laboratory examinations to
screen the existence of infection of the subjects.
From the data in Appendix 7, the subject leukocyte
level ranged from 9,100 to 13,900/mm3; implying
that the subjects were not being infected.
The previous study in 1980’s concluded that
there was a profile of estriol in the saliva during
pregnancy. Some groups of author, including
McGarrigle and Lachelin, Dame et al, and also Vin-
ing et al, indicated that the salivary conjugated/un-
conjugated estriol levels increased gradually up to
the fifth week before delivery; and then increased
more profound until the delivery time. By the de-
livery time, estriol was in an abundant form of free
estrogen that elevated by 718% in the last 20-week
of pregnancy and by 149% in the last sixth weeks
before delivery. These increase were also seen in
salivary estriol to progesteron ratio.23
In this study, as indicated in Table 2, there was
significant different levels of salivary estriol
(p<0.05) between the preterm delivery group and
the preterm pregnancy group. The mean salivary
estriol level in preterm delivery was 3438.75
(SD=3283.03), while the mean value of estriol in
preterm pregnancy was 686.10 (SD:279.22); and
the ranges were 1188-16338 and 88-1180 for each
groups, respectively.
Table 3 in this study shows that the association
of age to estriol level and of parity to estriol level
had p-value of 0.249 and 0.115, respectively. These
data implies that there were no correlation of age
to estriol level and of parity to estriol level.
From this study, salivary estriol level range in
preterm delivery was varied widely, i.e. 1188-
16338. This condition indicates that prematurity
was actually a multifactorial problem and there
was no given factor that can solely cause it. Some
factors that can influence the prematurity were
parity, pregnancy interval, history of premature de-
livery, age, marital status, nutrition, body weight
gain during pregnancy, pregestational body weight,
socioeconomy, and physical fatigue.
Thus, this study’s results can strengthen and
conform the previous studies’ results that the sali-
vary estriol level was higher in preterm delivery
compared to that in preterm pregnancy.
CONCLUSION
The mean value of salivary estriol level  in preterm
delivery was higher than that in preterm preg-
nancy.
The salivary estriol level can be applied as a pre-
dictor for preterm delivery.
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